MIRA INFORM REPORT
|
Report No. : |
320356 |
|
Report Date : |
30.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
INTAS PHARMACEUTICALS LIMITED (w.e.f. 10.03.1995) |
|
|
|
|
Formerly Known
As : |
INTAS LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered Office
: |
2nd Floor, Chinubhai Center, Ashram Road, Ahmedabad – 380009, Gujarat |
|
Tel No.: |
91-79-26576655 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
31.05.1985 |
|
|
|
|
Com. Reg. No.: |
04-007866 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.1144.363 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231GJ1985PLC007866 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
AHMI00350A |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACI5120L |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
The company engaged in the development,
manufacture, and marketing of pharmaceutical formulations. |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
A (68) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 80000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exists |
|
|
|
|
Comments : |
Subject is a well-established company having fine track record. Financial position of the company seems to be sound. Trade relations are reported as fair. Business is active. Payment terms
are reported to be regular and as per commitments. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long term bank facilities: AA+ |
|
Rating Explanation |
Have high degree of safety and carry very low credit risk. |
|
Date |
06.04.2015 |
|
Rating Agency Name |
CARE |
|
Rating |
Short term bank facilities: A1+ |
|
Rating Explanation |
Have carry strong degree of safety ad carry lowest credit risk. |
|
Date |
06.04.2015 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DECLINED
MANAGEMENT NON – COOPERATIVE (91-79-26576655)
LOCATIONS
|
Registered Office/
Corporate Office : |
2nd Floor, Chinubhai Center, Ashram Road, Ahmedabad – 380009, Gujarat,
India |
|
Tel. No.: |
91-79-26576655/26579052/26578269/26623100 |
|
Fax No.: |
91-79-26588862/26578862 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
400 Sq. Ft |
|
Location : |
Owned |
|
|
|
|
Factory 1 : |
Plot No. 457/458
, Sarkhej - Bavla Highway, Village: Matoda, Taluka: Sanand, Ahmedabad –
382210, Gujarat, India |
|
Tel. No.: |
91-2717-551111/
551298 |
|
Fax No.: |
91-2717-551106 |
|
|
|
|
Factory 2 : |
7/3, GIDC Estate,
Behind Dena Bank, Vatva, Ahmedabad –
382445, Gujarat, India |
|
Tel No : |
91-79-25831279 |
|
Fax No : |
91-79-25830207 |
|
|
|
|
Factory 3 : |
85/87 Kailash
Industrial Estate, Post Jyawa Taluka, Sanand, Ahmedabad, Gujarat, India |
|
Tel. No.: |
91-2717-284188 |
|
|
|
|
Factory 4 : |
Valia, Near Bharuch, Ankaleshwar, Gujarat, India |
DIRECTORS
AS ON 25.06.2013
|
Name : |
Mr. Nimish Hasmukh Bhai Chudgar |
|
Designation : |
Managing Director |
|
Address : |
3, Sanidhya Bunglows, Near Someshwar Jain Temple, Satellite, Ahmedabad-380015, Gujarat, India. |
|
Date of Birth/Age : |
19.08.1960 |
|
Qualification : |
B Sc |
|
Date of Appointment : |
01.04.2011 |
|
DIN No.: |
00212400 |
|
PAN No.: |
ABDPC6875B |
|
|
|
|
Name : |
Mr. Urmish Hasmukh Chudgar |
|
Designation : |
Managing Director |
|
Address : |
16, Nishant Bungalows, Satellite, Ahmedabad-380015, Gujarat, India |
|
Date of Birth/Age : |
16.02.1959 |
|
Qualification : |
MD in Oncology and Haemetoly |
|
Date of Appointment : |
01.09.2011 |
|
DIN No.: |
00096080 |
|
PAN No.: |
ABHPC1733G |
|
|
|
|
Name : |
Mr. Binish Hasmukh Chudgar |
|
Designation : |
Vice Chairman and Managing Director |
|
Address : |
502- Heritage Cresent Apartment, B/H Auda Garden, Satellite, Ahmedabad-380015, Gujarat, India. |
|
Date of Birth/Age : |
01.12.1963 |
|
Qualification : |
B Com MBA |
|
Date of Appointment : |
01.04.2011 |
|
DIN No.: |
00119503 |
|
PAN No.: |
ABDPC6876C |
|
|
|
|
Name : |
Mr. Hasmukh Chudgar |
|
Designation : |
Managing Director |
|
Address : |
13-14, Sanidhya Bunglows, Near Someshwar Complex, Shyarnal Cross Road, Satellite, Ahmedabad-380015, Gujarat, India. |
|
Date of Birth/Age : |
16.05.1933 |
|
Qualification : |
B Pharm |
|
Date of Appointment : |
01.07.2009 |
|
DIN No.: |
00172265 |
|
PAN No.: |
AARPC4022H |
|
|
|
|
Name : |
Mr. Nitin Ram Potdar |
|
Designation : |
Additional director |
|
Address : |
42A/402, Sumer Trinity Tower, Behind Marathe Udyog Bhuvan, New Prabhadevi, Mumbai -400 025, Maharashtra, India |
|
Date of Birth/Age : |
21.02.1963 |
|
Date of Appointment : |
12.08.2011 |
|
DIN No.: |
00452644 |
|
|
|
|
Name : |
Mr. John Goddard |
|
Designation : |
Director |
|
Address : |
38, Delvino Road London SW64AJ, United Kingdom |
|
Date of Birth/Age : |
19.07.1951 |
|
Date of Appointment : |
12.08.2011 |
|
Din No: |
03420601 |
|
|
|
|
Name : |
Mr. Hemant D. Sheth |
|
Designation : |
Director |
|
Address : |
201, Aangan, Plot No 40, T.V.Chidambaram Marg, Sion (East) Mumbai- 400022, Maharashtra, India |
|
Date of Birth/Age : |
29.11.1961 |
|
Date of Appointment : |
12.08.2011 |
|
Din No: |
01261486 |
|
|
|
|
Name : |
Mr. Surender Tuteja |
|
Designation : |
Director |
|
Address : |
S- 307, IInd Floor, Panchsheel Park, New Delhi- 110017 |
|
Date of Birth/Age : |
15.06.1945 |
|
Date of Appointment : |
12.08.2011 |
|
Din No: |
00594076 |
|
|
|
|
Name : |
Mr. Tilokchand P.Ostwal |
|
Designation : |
Director |
|
Address : |
103, 104 Falcon’s Cres, G.D. Ambedkar Marg, Parel, Mumbai-400012 |
|
Date of Birth/Age : |
20.10.1979 |
|
Date of Appointment : |
12.08.2011 |
|
Din No: |
00821268 |
|
Name : |
Mr. Kaul D Sanjiv |
|
Designation : |
Nominee Director |
|
Address : |
22, Siris Rao, DLF Phase – 3, Gurgaon – 122002, India |
|
Date of Birth/Age : |
25.07.1957 |
|
Date of Appointment : |
16.06.2012 |
|
Din No: |
01550413 |
KEY EXECUTIVES
|
Name : |
Mr. Manoj Narayanan Nair |
|
Designation : |
Company Secretary |
|
Address : |
Plot No. 648/1, Sector-4 C, Gandhinagar – 382006, Gujarat, India |
|
Date of Birth/Age : |
20.10.1979 |
|
Date of Appointment : |
08.06.2007 |
|
PAN No.: |
AEBPN7909Q |
MAJOR SHAREHOLDERS
AS ON 26.03.2013
|
Names of Shareholders |
|
No. of Shares |
|
Nimish H Chudgar |
|
6438707 |
|
Binish H Chudgar |
|
6209147 |
|
Umish H Chudgar |
|
113533 |
|
Kusumben H Chudgar |
|
2367503 |
|
Bindiben B Chudgar |
|
6906389 |
|
Parulben U Chudgar |
|
6994369 |
|
Binaben N Chudgar |
|
5444829 |
|
Hasmukh K Chudgar |
|
3597487 |
|
Equatorial Private Limited, India
|
|
47432000 |
|
Mozart Limited, Mauritius |
|
11621100 |
|
Intas Enterprise Private Limited, India |
|
4106667 |
|
Chudgar U. Shall |
|
4796967 |
|
Caravaggio, Mauritius |
|
6898447 |
|
Cytas Research Limited, India |
|
1509131 |
|
|
|
|
|
Total |
|
114436276 |
Equity Share Break up (Percentage of Total Equity)
AS ON 26.03.2013
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
16.18 |
|
Bodies corporate |
46.36 |
|
Directors or relatives of Directors |
37.46 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
The company engaged in the development,
manufacture, and marketing of pharmaceutical formulations. |
||||||||
|
|
|
||||||||
|
Products : |
|
||||||||
|
|
|
||||||||
|
Brand Names : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Agencies Held : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Exports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Imports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Terms : |
Not Divulged |
GENERAL INFORMATION
|
Suppliers : |
Not Divulged |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Customers : |
Not Divulged |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
|
|
|
|
|
Financial Institution : |
|
|
|
|
|
Auditors : |
|
|
Name : |
Apaji Amin and Company Chartered Accountants |
|
Address : |
304, Akansha Building, Opposite Vadilal House, Navrangpura. Ahmedabad -380 009, Gujarat, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAFFA6140C |
|
|
|
|
Subsidiary company: |
|
|
|
|
|
Enterprises which
are owned, or have
significant influence of or are
partners with Key management personnel and their relatives: |
[U24236GJ1998PLC034883]
[U74300GJ2001PLC046472]
[U85195GJ2009PLC057059]
[U19129GJ1997NPL032264]
|
CAPITAL STRUCTURE
As on 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
168916752 |
Equity Shares |
Rs.10/- each |
Rs.1689.168 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
114436276 |
Equity Shares |
Rs.10/- each |
Rs.1144.363
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
1144.363 |
1144.363 |
1034.767 |
|
(b) Reserves & Surplus |
26890.147 |
21152.338 |
12077.184 |
|
(c) Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
28034.510 |
22296.701 |
13111.951 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
1023.875 |
1166.829 |
3075.547 |
|
(b) Deferred tax liabilities
(Net) |
730.497 |
632.367 |
228.847 |
|
(c) Other long term
liabilities |
198.453 |
197.795 |
170.179 |
|
(d) long-term provisions |
410.386 |
355.928 |
293.111 |
|
Total
Non-current Liabilities (3) |
2363.211 |
2352.919 |
3767.684 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
4631.483 |
5539.665 |
5504.697 |
|
(b) Trade payables |
6071.607 |
7311.506 |
4512.412 |
|
(c) Other current liabilities |
761.476 |
1317.970 |
1942.307 |
|
(d) Short-term provisions |
334.711 |
267.770 |
240.526 |
|
Total
Current Liabilities (4) |
11799.277 |
14436.911 |
12199.942 |
|
|
|
|
|
|
TOTAL |
42196.998 |
39086.531 |
29079.577 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
7908.565 |
6645.833 |
2680.851 |
|
(ii) Intangible Assets |
1541.443 |
1680.020 |
154.546 |
|
(iii) Capital work-in-progress |
456.499 |
385.797 |
420.812 |
|
(iv) Intangible assets under
development |
2820.599 |
3535.083 |
525.029 |
|
(b) Non-current Investments |
5677.156 |
5256.685 |
8682.568 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
2493.294 |
3391.504 |
3256.436 |
|
(e) Other Non-current assets |
6.308 |
59.893 |
51.337 |
|
Total
Non-Current Assets |
20903.864 |
20954.815 |
15771.579 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
44.111 |
0.000 |
|
(b) Inventories |
6270.865 |
6161.054 |
4646.117 |
|
(c) Trade receivables |
12896.168 |
9875.314 |
6934.153 |
|
(d) Cash and cash equivalents |
287.400 |
243.381 |
189.309 |
|
(e) Short-term loans and advances |
1838.701 |
1807.856 |
1538.419 |
|
(f) Other current assets |
0.000 |
0.000 |
0.000 |
|
Total
Current Assets |
21293.134 |
18131.716 |
13307.998 |
|
|
|
|
|
|
TOTAL |
42196.998 |
39086.531 |
29079.577 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
SALES |
|
|
|
|
|
Income |
40957.989 |
33976.677 |
26222.167 |
|
|
Other Income |
589.725 |
141.292 |
292.114 |
|
|
TOTAL
(A) |
41547.714 |
34117.969 |
26514.281 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
10248.214 |
760.982 |
5856.996 |
|
|
Purchases of Stock-in-Trade |
9466.730 |
8200.514 |
7500.920 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
136.045 |
99.837 |
(905.566) |
|
|
Employees benefits expense |
3421.821 |
2979.093 |
1902.377 |
|
|
Other expenses |
9720.877 |
7430.318 |
6103.221 |
|
|
TOTAL
(B) |
32993.687 |
19470.744 |
20457.948 |
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (C) |
8554.027 |
14647.225 |
6056.333 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
340.019 |
588.992 |
774.974 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
8214.008 |
14058.233 |
5281.359 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION (F) |
973.075 |
754.570 |
302.275 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F) (G) |
7240.933 |
13303.663 |
4979.084 |
|
|
|
|
|
|
|
Less |
TAX
(I) |
1168.410 |
833.708 |
550.118 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-I)
(J) |
6072.523 |
12469.955 |
4428.966 |
|
|
|
|
|
|
|
|
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
10897.646 |
5630.035 |
2791.595 |
|
|
|
|
|
|
|
|
ARISE
ON SCHEME OF MERGER |
0.000 |
665.429 |
0.000 |
|
|
|
|
|
|
|
|
APPROPRIATIONS |
|
|
|
|
|
Proposed Equity Dividend |
286.091 |
228.873 |
206.953 |
|
|
Corporate Dividend Tax |
48.621 |
38.897 |
33.573 |
|
|
General Reserve |
700.000 |
600.000 |
1000.000 |
|
|
Transfer to Capital Redemption
Reserve |
0.000 |
0.000 |
0.000 |
|
|
Transfer to Debenture
Redemption Reserve |
0.000 |
0.000 |
350.000 |
|
|
Balance
Carried to the B/S |
15552.399 |
10897.646 |
5630.035 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
Export Earnings |
18569.039 |
13599.709 |
9808.451 |
|
|
TOTAL
EARNINGS |
18569.039 |
13599.709 |
9808.451 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
55.02 |
48.41 |
42.80 |
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin PAT/ Sales |
(%) |
14.83 |
36.70 |
16.89 |
|
|
|
|
|
|
|
PBIDT / Sales |
(%) |
20.88 |
43.11 |
23.10 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
21.78 |
44.48 |
25.60 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.26 |
0.60 |
0.38 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.20 |
0.30 |
0.65 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.80 |
1.26 |
1.09 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Share Capital |
1034.767 |
1144.363 |
1144.363 |
|
Reserves & Surplus |
12077.184 |
21152.338 |
26890.147 |
|
Net
worth |
13111.951 |
22296.701 |
28034.510 |
|
|
|
|
|
|
long-term borrowings |
3075.547 |
1166.829 |
1023.875 |
|
Short term borrowings |
5504.697 |
5539.665 |
4631.483 |
|
Total
borrowings |
8580.244 |
6706.494 |
5655.358 |
|
Debt/Equity
ratio |
0.654 |
0.301 |
0.202 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
26222.167 |
33976.677 |
40957.989 |
|
|
|
29.572 |
20.547 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
26222.167 |
33976.677 |
40957.989 |
|
Profit |
4428.966 |
12469.955 |
6072.523 |
|
|
16.89% |
36.70% |
14.83% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
Yes |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
LITIGATION DETAILS
HIGH COURT OF GUJARAT
FIRST APPEAL No. 2429 of 2011
|
Status : PENDING
|
( Converted from : FAST/2121/2011 ) |
CCIN No : 001012201102429 |
|
||||||||||||
|
||||||||||||
|
S.NO. |
Name of the Petitioner |
Advocate On Record |
||||||||||
|
1 |
RAMESHBHAI RAMJIBHAI CHAVDA |
MR.HIREN M MODI for: Appellant(s) 1 |
||||||||||
|
S.NO. |
Name of the Respondant |
Advocate On Record |
||||||||||
|
1 |
RAMAKANT GIRISHCHANDRA SHUKLA |
RULE SERVED for :Defendant(s) 1 - 2 |
||||||||||
|
Presented On |
: 08/08/2011 |
Registered On |
: 08/08/2011 |
|||||||||
|
Bench Category |
: SINGLE BENCH |
District |
: VADODARA |
|||||||||
|
Case Originated From |
: THROUGH HIS/HER/THEIR ADVOCATE |
Listed |
: 10 times |
|||||||||
|
StageName |
: BOARD NO. I (NOTICE & ADJOURNED MATTERS) |
|||||||||||
|
Classification |
|
|
Act |
|
LowerCourt Details
|
|
S.No. |
LowerCourt CaseDetail |
LowerCourtName |
JudgeName |
Judgmentdate |
|
1 |
MACP/1636/2007 |
DISTRICT COURT, VADODARA |
K.B.MAGHNANI-JT DIST. JUDGE & ADDL. SESSIONS JUDGE |
07/05/2011 |
Office Details
|
||||
|
S. No. |
Filing Date |
Document Name |
Advocate Name |
Court Fee on
Document |
Document Details |
|
1 |
08/08/2011 |
MEMO OF PETITION/APPEAL/SUIT |
MR.HIREN M MODI ADVOCATE |
10 |
MR.HIREN M MODI:1 |
|
2 |
08/08/2011 |
CERTIFIED COPY |
MR.HIREN M MODI ADVOCATE |
12 |
MR.HIREN M MODI:1 |
|
3 |
15/08/2011 |
VAKALATNAMA |
MR AJAY R MEHTA ADVOCATE |
4 |
MR AJAY R MEHTA:3 |
|
4 |
15/08/2011 |
VAKALATNAMA |
MR YOGEN N PANDYA ADVOCATE |
4 |
MR YOGEN N PANDYA:2 |
|
5 |
15/08/2011 |
VAKALATNAMA |
MR.HIREN M MODI ADVOCATE |
- |
MR.HIREN M MODI:1 |
|
6 |
15/08/2011 |
DOCUMENT |
RULE SERVED |
- |
RULE SERVED:1,2 |
|
7 |
09/09/2011 |
VAKALATNAMA |
MR.HIREN M MODI ADVOCATE |
5 |
MR.HIREN M MODI:1 |
|
8 |
09/09/2011 |
MEMO OF PETITION/APPEAL/SUIT |
MR.HIREN M MODI ADVOCATE |
3000 |
MR.HIREN M MODI:1 |
|
9 |
30/11/2011 |
VAKALATNAMA |
MR AJAY R MEHTA ADVOCATE |
5 |
MR AJAY R MEHTA:3 |
|
10 |
13/01/2012 |
VAKALATNAMA |
MR YOGEN N PANDYA ADVOCATE |
5 |
MR YOGEN N PANDYA:2 |
Court Proceedings
|
|||||
|
S. No. |
Notified Date |
CourtCode |
Board Sr. No. |
Stage |
Action |
Coram |
|
1 |
25/08/2011 |
17 |
- |
OFFICE OBJECTION REMOVED |
NEXT DATE |
· HONOURABLE MR.JUSTICE RAJESH H.SHUKLA |
|
2 |
20/09/2011 |
17 |
35 |
BOARD NO. I (NOTICE & ADJOURNED MATTERS) |
NEXT DATE |
· HONOURABLE MR.JUSTICE G.B.SHAH |
|
3 |
03/10/2011 |
17 |
- |
BOARD NO. I (NOTICE & ADJOURNED MATTERS) |
RULE/ADMIT |
· HONOURABLE MR.JUSTICE G.B.SHAH |
Available Orders
|
||||||
|
S. No. |
Case Details |
Judge Name |
Order Date |
CAV |
Judgement |
Questions |
Transferred |
|
1 |
FIRST APPEAL/2429/2011 |
· HONOURABLE MR.JUSTICE G.B.SHAH |
03/10/2011 |
N |
ORDER |
- |
Y |
REVIEW OF OPERATIONS
During the year, the company has achieved sales of Rs. 41101.521 Million as compared to Rs. 34132.813 Million in the previous year representing a growth of 20%.
The EBIDTA was Rs. 8554.028 Million increased from Rs. 7647.221 Million in the previous year representing a growth of 12%. The PBT was Rs. 7240.934 Million increased from Rs. 6303.659 Million in the previous year representing a growth of 15%. The Net profit was Rs. 6072.523 Million increased from Rs. 5469.952 Million in the previous year representing a growth of 11% The Earning Per Share was Rs. 55.02 as compared to Rs.48.41.
DOMESTIC BUSINESS
The Company retained its leading positions in the domestic market and has maintained its current ranking of the 12th largest pharmaceutical company in India in terms of market share, based on domestic sales of formulations (Source: IMS March 2014) and has presence in various major therapy areas with a strong focus on growth oriented therapy areas relating to neurology, psychiatry, cardiology diabetology, urology, nephrology and pain management. The company enjoys a dominant position in chronic therapy segments which contributes around 60% of their domestic sales and has scaled up its strategy in oncology, biosimilar and critical care segments.The Company is focussed on growing organically in areas where they are currently present and intend to introduce new therapies to complement their existing product basket.
In this fragmented domestic pharmaceutical market, the company has achieved a turnover of Rs. 19781.558 Million as compared to Rs. 16886.137 Million in the previous year representing a growth of 17%.
Recently the company has launched Nanosomal Docetaxel Lipid Suspension (NDLS), DoceAqualip, created using the Nano Aqualip Technology and designed to reduce significantly the hypersensitivity of the drug among the patients. This has received very good response from medical fraternity.
The company has developed several product brands under each of the therapy areas. Their leading top brands are ZORYL M, LEVERA, LIPICURE, LOOZ, VALPROL CR, ZORYL, HIFENAC-P, GABAPIN NT, CEFTAS, VELTAM PLUS. The Company believes that the growth of their business depends on launching new products in the domestic market and making them successful. The company has maintained a consistent record of new product launches for the last several years. During the year, the company has initiated several new launches.
The fastest growing top brands of the company are ESPIN, ESPIN AT, MECOFOL PLUS-NF, ANTIPREG-KIT, I-KUL PLUS, HALD, URIBID, LUKOTAS 3D, TERIFRAC, KULFDRYL, ZORYL-M FORTE, LOOZ, GABAPIN NT, TAH, LOPEZ. The company has a well diversified portfolio of products featuring in first 3 ranks in the industry. These products portfolio contribute to about 46 % of the total domestic sales.
UNSECURED LOAN
|
Unsecured Loan |
31.03.2014 (Rs.
in Million) |
31.03.2013 (Rs.
in Million) |
|
Long-term
Borrowings |
|
|
|
Loans and advances from related parties |
0.000 |
456.000 |
|
Other loans and advances |
75.875 |
73.700 |
|
Short-term
borrowings |
|
|
|
Foreign currency term loans from banks |
2320.957 |
2192.078 |
|
Rupee term loans from banks |
216.868 |
315.961 |
|
Total |
2613.700 |
3037.739 |
INDEX
OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10443209 |
14/06/2013 |
900,000,000.00 |
IDBI TRUSTEESHIP SERVICES LIMITED |
ASIAN BLDG., GROUND FLOOR, 17, R.KAMANI MARG, BALLARD ESTATE,, MUMBAI, MAHARASHTRA - 400001, INDIA |
B80823800 |
|
2 |
10373035 |
14/02/2014 * |
181,120,000.00 |
BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL |
A-254, 3RD FLOOR,
VEERA TOWER, BHISHAM PITAMAH M |
B97953426 |
|
3 |
10256338 |
24/02/2014 * |
500,000,000.00 |
CITI BANK N.A. |
301, 3RD FLOOR,
REMBRANT BUILDING,, OPP. ASSOCIAT |
B98651003 |
|
4 |
10237974 |
31/03/2011 * |
500,000,000.00 |
CITI BANK N.A. |
301, 3RD FLOOR,
REMBRANT BUILDING,, OPP. ASSOCIAT |
B12685574 |
|
5 |
10242942 |
31/03/2011 * |
500,000,000.00 |
CITIBANK N. A. |
301, 3RD FLOOR,
REMBRANT BUILDING,, OPP. ASSOCIAT |
B12696878 |
|
6 |
10216795 |
25/03/2010 |
1,050,000,000.00 |
IDBI TRUSTEESHIP SERVICES LIMITED |
ASIAN BLDG., GROUND FLOOR, 17, R.KAMANI MARG, BALLARD ESTATE, MUMBAI, MAHARASHTRA - 400001, INDIA |
A84363340 |
|
7 |
10187006 |
16/06/2010 * |
1,050,000,000.00 |
IDBI TRUSTEESHIP SERVICES LIMITED |
ASIAN BLDG. GROUND FLOOR, 17, R.KAMANI MARG, BALLARD ESTATE,, MUMBAI, MAHARASHTRA - 400001, INDIA |
A88556238 |
|
8 |
90103163 |
21/08/2014 * |
5,500,000,000.00 |
STATE BANK OF INDIA |
COMMERCIAL BRANCH,
PARAMSIDDHI COMPLEX, ELLISBRID |
C18867440 |
|
9 |
90107682 |
01/05/1998 |
45,000,000.00 |
DENA BANK |
ASHRAM ROAD BRANCH,
ASHRAM ROAD, AHMEDABAD, GUJAR |
- |
* Date of charge modification
FIXED ASSETS
Tangible assets
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
- Computer equipments
Intangible assets
- Patents
- Licenses and franchise
- Know-how
- Commercial contractual rights
- Computer software
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.20 |
|
|
1 |
Rs.91.01 |
|
Euro |
1 |
Rs.69.34 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILITY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
8 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
68 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.